12Dec/16
veeva-logo

Unifying Applications to Drive Effectiveness, Efficiency and Compliant Collaboration

By: Sandra K. Rodriguez, Market Analyst

Using a Cloud Platform to Connect the Life Science Value Chain

Pharmaceutical, Bio-Tech and Medical Device companies are increasingly adopting cloud platforms to drive effectiveness and efficiency throughout the value chain.  These organizations are unifying applications that support the total product lifecycle in a compliant manner, without losing sight of what matters most – product quality.

This shift from disconnected point solutions to a platform approach became clear at the Veeva Systems Global Summit for Clinical, Regulatory, and Quality in Philadelphia on October 17-19, 2016, where I joined over 600 attendees representing 154 companies.  Client presentations ranged from start-up to multi-national Life-Science companies including Regeneron, Shire and Johnson & Johnson. A list of presenters can be found here.

Jennifer Goldsmith, Senior Vice President, Veeva Vault

Jennifer Goldsmith, Senior Vice President, Veeva Vault

Jennifer Goldsmith, Senior Vice President, Veeva Vault kicked off the event by celebrating the five-year birthday of Vault.  This was my first time covering the event and I was immediately surprised by the opening keynote delivered by Peter Gassner, CEO at Veeva Systems.  He revealed that over the past three years, the company has consistently doubled its customer base across all three of its product offerings – Vault Clinical, Vault Quality and Vault Regulatory.  Sessions were offered across all three areas including a track on platforms and a focus on small and mid-size organizations. Continue reading

11Oct/16
closed-loop-process-with-copyright-wp5

Does Having a Closed Loop Process Really Matter to Your Business?

New White Paper: The Future of Change and Configuration Management in the Med-Tech Industry

Recalls are on the rise. How can you avoid them?

Analysis shows a 97% increase in the annual number of medical device recalls for the 10-year period, increasing from 604 recalls in FY 2003 to 1,190 recalls in FY 2012. 

Want to learn how a Closed Loop Process can prevent recalls, drive accelerated innovation, improve product quality and enhance company performance?  Does Having a Closed Loop Process Really Matter?

Download the white paper to find out how Med-Tech Innovators are avoiding recalls by implementing closed loop change and configuration management processes.

Contact: research@axendia.com to see if you qualify for a complimentary access code and save $499.
29Sep/16
gudid

Hear Directly from FDA: Are You Done with UDI or Is This Just the Beginning?

Webinar Announcement 

Are you done with UDI… or is it just the beginning?  Hear directly from FDA’s Senior Advisor for UDI and Industry Experts the profound effect UDI implementation will have on Med-Tech manufacturers, healthcare providers, regulators and ultimately the patient.

On Oct. 13th at 1:30pm Eastern, join Terrie Reed, Senior Advisor for UDI Adoption at the FDADaniel R. Matlis of Axendia, and Jean Colombel of Dassault Systemes as they discuss UDI and how its value resides in the ability to optimize meaningful data collection and analysis.

Continue reading

27Sep/16
man-jumping-over-the-ledge-wp4

Don’t Solve Quality Problems, Avoid Them

New White Paper: The Future of Change and Configuration Management in the Med-Tech Industry

Can you distribute poor quality products while complying with all applicable regulatory requirements? Sure! After all, you can conduct a recall of poor quality products in compliance with all applicable regulations.  FDA’s Top Medical Device official agrees.

Jeff Shuren, M.D., J.D., Director of FDA’s Center for Devices and Radiological Health (CDRH), put it this way: “…one device manufacturer can meet FDA requirements and still make a poor quality device; whereas, a second manufacturer may not comply with all FDA requirements and yet make a high-quality device.”

Is your organization focused on Solving Quality Problems or Avoiding Them?  Download the white paper to find out how Med-Tech Innovators have been able to shift their focus on improving market presence, manufacturing processes and product quality.

Contact: research@axendia.com to see if you qualify for a complimentary access code and save $499.
21Sep/16
Data Integrity in LS

Data Integrity – A Requirement for FDA Compliance, Quality and Beyond

On Demand Webinar Announced

Data integrity and quality are foundational for regulatory compliance and good science, an issue that was recently highlighted by the new “FDA Guidance for Data Integrity and Compliance with cGMP”. This guidance was issued to address a growing number of data integrity violations and underscores the importance of data quality and integrity to support intellectual property protection and patient filings in regulated and non-regulated spaces.

DownloadData Integrity in Life Sciences a PDF of this inforgraphic.

We discuss what Goldilocks and Life-Sciences companies have in common during the webinar. An on demand recording is available here.